Table 6.
Characteristics | CSF and/or blood culture and PCR positive (n = 67) | PCR positive (n = 43) | P valuea |
---|---|---|---|
General information | |||
Age, median (IQR) | 48 (38–56) | 53 (45–61) | 0.026 |
Male sex (n, %) | 57 (85.1) | 34 (79.1) | 0.416 |
Residence (rural) (n, %) | 53 (79.1) | 32 (74.41) | 0.567 |
Underlying diseases and exposure | |||
Diabetes mellitus (n, %) | 1 (1.5) | 6 (13.0) | 0.010 |
Alcoholism (n, %) | 8 (11.9) | 2 (4.7) | 0.194 |
Pig exposure (n, %) | 26 (38.8) | 14 (32.6) | 0.506 |
Clinical manifestations | |||
Days of illness, median (IQR) | 3 (3–5) | 5 (4–7) | 0.004 |
Antimicrobial therapy before admission (n, %) | 35 (53.2) | 38 (88.4) | <0.001 |
Fever (n, %) | 65 (97.0) | 42 (97.7) | 0.522 |
Headache (n, %) | 67 (100) | 42 (97.7) | 0.391 |
Nausea/vomiting (n, %) | 49 (73.1) | 27 (62.8) | 0.252 |
Neck stiffness (n, %) | 61 (91.0) | 40 (93.0) | 1.000 |
Glasgow Coma Score, median (IQR) | 12 (9–14) | 13 (9–15) | 0.159 |
Tinnitus (n, %) | 50 (74.6) | 27 (62.8) | 0.118 |
Deafness (n, %) | 19 (28.4) | 11 (25.6) | 0.714 |
Skin injuries (n, %) | 18 (26.9) | 13 (30.2) | 0.702 |
Herpes labialis (n, %) | 29 (43.3) | 21 (48.8) | 0.568 |
Laboratory investigations median (IQR) | |||
▪ Blood | |||
White blood cells (103/L) | 18 000 (12 400–23 000) | 16 840 (12 600–23 550) | 0.941 |
Neutrophil (%) | 88 (83–91) | 86.3 (80.3–90) | 0.131 |
▪ CSF | |||
White cells (103/L) | 1570 (760–3480) | 1340 (340–2900) | 0.153 |
Neutrophil (%) | 86 (74–91) | 70 (49–85) | 0.002 |
Protein (g/L) | 1.6 (1.3–2) | 1.63 (1.2–2) | 0.402 |
CSF/blood glucose ratio | 0.24 (0.15–0.31) | 0.40 (0.29–0.5) | <0.001 |
Lactate (mmol/L) | 11.2 (6.8–15.7) | 5.73 (4.4–8.3) | <0.001 |
Outcome (survival) | 67 (100) | 40 (100)b |
Determined using Fisher exact test or Wilcoxon rank-sum test, as appropriate.
Three patients were transferred to other hospitals and their outcomes are unknown.